Search research articles
Contact Us
Filters
Showing results (231-240 of 236) with videos related to
Page
of 24
Sort By:
You have reached the last page of results.
This site can display upto 236 results.
Egastroenterology
|
January 26, 2026
Reduced fibre-fermenting capacity of gut microbes in multiple sclerosis may result in prebiotic dietary fibre β-fructan promoting inflammation and CNS damage
Stephanie L Tollenaar, Reihane Khorasaniha, Juan Jovel, et al.
Journal of Medicinal Chemistry
|
April 9, 2026
From KRAS<sup><i>G12D</i></sup> to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
Xiaoshen Ma, David L Sloman, Timothy J Henderson, et al.
Journal of Medicinal Chemistry
|
March 3, 2022
Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing
Derun Li, David L Sloman, Abdelghani Achab, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Carbamate and <i>N</i>-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors
Derun Li, Yongqi Deng, Abdelghani Achab, et al.
The Journal of Experimental Medicine
|
September 26, 2007
Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity
Cheng-Lung Ku, Horst von Bernuth, Capucine Picard, et al.
Journal of Medicinal Chemistry
|
April 29, 2026
Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual Inhibitors
Xiao Mei Zheng, David A Candito, James Jewell, et al.
Page
of 24
Search research articles
Search
Showing results (231-240 of 236) with videos related to
Sort By:
Page
of 24
You have reached the last page of results.
This site can display upto 236 results.
Egastroenterology
|
January 26, 2026
Reduced fibre-fermenting capacity of gut microbes in multiple sclerosis may result in prebiotic dietary fibre β-fructan promoting inflammation and CNS damage
Stephanie L Tollenaar, Reihane Khorasaniha, Juan Jovel, et al.
Journal of Medicinal Chemistry
|
April 9, 2026
From KRAS<sup><i>G12D</i></sup> to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design
Xiaoshen Ma, David L Sloman, Timothy J Henderson, et al.
Journal of Medicinal Chemistry
|
March 3, 2022
Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing
Derun Li, David L Sloman, Abdelghani Achab, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Carbamate and <i>N</i>-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors
Derun Li, Yongqi Deng, Abdelghani Achab, et al.
The Journal of Experimental Medicine
|
September 26, 2007
Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity
Cheng-Lung Ku, Horst von Bernuth, Capucine Picard, et al.
Journal of Medicinal Chemistry
|
April 29, 2026
Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual Inhibitors
Xiao Mei Zheng, David A Candito, James Jewell, et al.
Page
of 24